Identification and characterization of OGG1 mutations in patients with Alzheimer's disease

Guogen Mao, Xiaoyu Pan, Bei Bei Zhu, Yanbin Zhang, Fenghua Yuan, Jian Huang, Mark A. Lovell, Maxwell P. Lee, William R. Markesbery, Guo Min Li, Liya Gu

Research output: Contribution to journalArticlepeer-review

90 Scopus citations


Patients with Alzheimer's disease (AD) exhibit higher levels of 8-oxo-guanine (8-oxoG) DNA lesions in their brain, suggesting a reduced or defective 8-oxoG repair. To test this hypothesis, this study investigated 14 AD patients and 10 age-matched controls for mutations of the major 8-oxoG removal gene OGG1. Whereas no alterations were detected in any control samples, four AD patients exhibited mutations in OGG1, two carried a common single base (C796) deletion that alters the carboxyl terminal sequence of OGG1, and the other two had nucleotide alterations leading to single amino acid substitutions. In vitro biochemical assays revealed that the protein encoded by the C796-deleted OGG1 completely lost its 8-oxoG glycosylase activity, and that the two single residue-substituted OGG1 proteins showed a significant reduction in the glycosylase activity. These results were consistent with the fact that nuclear extracts derived from a limited number of AD patients with OGG1 mutations exhibited greatly reduced 8-oxoG glycosylase activity compared with age-matched controls and AD patients without OGG1 alterations. Our findings suggest that defects in OGG1 may be important in the pathogenesis of AD in a significant fraction of AD patients and provide new insight into the molecular basis for the disease.

Original languageEnglish (US)
Pages (from-to)2759-2766
Number of pages8
JournalNucleic acids research
Issue number8
StatePublished - Apr 2007

ASJC Scopus subject areas

  • Genetics


Dive into the research topics of 'Identification and characterization of OGG1 mutations in patients with Alzheimer's disease'. Together they form a unique fingerprint.

Cite this